• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构：
    • 成为企业机构
    • 个人用户：
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Establishment of Ovarian Cancer Cell Lines

        互联网

        640
        Human tumor cell lines have provided valuable model systems to study a wide variety of tumor characteristics including the cell biology, genetics, and chemosensitivity profiles of disease. A large number of ovarian cancer cell lines have now been established and are in widespread use Table 1 ) (1 -15 ). Many of these have been selected to reflect specific situations, e.g., pre- and postchemotherapy models or different histo- logical subtypes.
        Table 1  Properties of Established Ovarian Carcinoma Cell Lines
             

        Prior

        		  

        Cell Line

        Histology

        Source

        Treatment

        Ref.

        PE01

        P.D. Serous adenoca

        Ascites

        P/FU/CHL

        1

        PE04

        P.D. Serous adenoca

        Ascites

        P/FU/CHL

        1

        PE06

        P.D. Serous adenoca

        Ascites

        P/FU/CHL

        2

        PEA1

        P.D. Adenoca

        Pleural

        None

        2

        PEA2

        P.D. Adenoca

        Ascites

        P/Pred

        2

        PE016

        P.D. Serous adenoca

        Ascites

        Radioth

        2

        PE014

        W.D.Serous adenoca

        Ascites

        None

        2

        T014

        W.D.Serous adenoca

        Sol. Met

        None

        2

        PE023

        W.D.Serous adenoca

        Ascites

        P/CHL

        2

        SKOV-3

        Adenoca

        Ascites

        T

        3

        SW626

        Adenoca

        ―

        ―

        3

        OVCAR-2

        Adenoca

        Ascites

        P/Cy

        4

        OVCAR-3

        P.D. papillary adenoca

        Ascites

        P/Cy/Adr

        5

        OVCAR-4

        Adenoca

        Ascites

        P/Cy/Adr

        6

        OVCAR-5

        Adenoca

        Ascites

        None

        7

        OAW 28

        Adenoca

        Ascites

        P / Mel

        8

        OAW 42

        Serous adenoca

        Ascites

        P

        8

        41M

        Adenoca

        Ascites

        None

        9

        59M

        Endometr adenoca

        Ascites

        None

        8

        CH1

        Papillary adenoca

        Ascites

        P/ JM8

        8

        138D

        Serous adenoca

        Ascites

        Carb

        9

        180D

        Adenoca

        Ascites

        P

        9

        200D

        Serous adenoca

        Solid

        None

        9

        253D

        Serous adenoca

        Ascites

        Cy/MPA

        9

        HOC-1

        W.D. Serous adenoca

        Ascites

        None

        10

        HOC-7

        W.D. Serous adenoca

        Ascites

        None

        10

        CAOV-3

        Adenoca

        Tumour

        Cy/Adr/FU

        10

        COLO 110

        Serous adenoca

        Sol. Met

        None

        11

        COLO 316

        Serous adenoca

        Pleural

        None

        11

        COLO 319

        Serous adenoca

        Ascites

        None

        11

        COLO 330

        Serous adenoca

        Ascites

        Mel/Radiother

        11

        IGROV1

        Adenoca

        Primary

        None

        12

        HTOA

        W.D. serous adenoca

        Primary

        None

        13

        OV-1063

        Papillary adenoca

        Ascites

        Cy/Adr/P/HMM

        14

        DO-s

        W.D. mucinous adenoca

        Ascites

        ―

        15
        P.D. = Poorly differentiated; W.D. = Well differentiated; adenoca = adenocarcinoma; pleural = pleural effusion; Sol.met. = solid metastasis; P = cisplatin; FU = 5-fluorouracil; CHL = chlorambucil; Pred = prednimustine; Radioth = radiotherapy; T = thiotepa; Cy = cyclophosphamide; Adr = adriamycin; Mel = melphalan; Carb = carboplatin; MPA = medroxyprogesterone actetate; HMM = examethylmelamine.
        ad image
        ad image

        相关产品推荐

        Hemagglutinin/HA重组蛋白|Recombinant H1N1 (A/California/04/2009) HA-specific B cell probe (His Tag)

        Hemagglutinin/HA重组蛋白|Recombinant H1N1 (A/California/04/2009) HA-specific B cell probe (His Tag)

        ￥2570

        ENOX2/ENOX2蛋白Recombinant Human Ecto-NOX disulfide-thiol exchanger 2 (ENOX2)重组蛋白APK1 antigen (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) (COVA1)蛋白

        ENOX2/ENOX2蛋白Recombinant Human Ecto-NOX disulfide-thiol exchanger 2 (ENOX2)重组蛋白APK1 antigen (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) (COVA1)蛋白

        ￥1836

        LINES rabbit pAb

        LINES rabbit pAb

        ￥900

        Single Cell WGA Kit（MDA），阿拉丁

        Single Cell WGA Kit（MDA），阿拉丁

        ￥6897.90

        Cell Cycle Assay Kit Plus（细胞周期检测试剂盒升级版），阿拉丁

        Cell Cycle Assay Kit Plus（细胞周期检测试剂盒升级版），阿拉丁

        ￥1080.90

        相关问答

        问

        Journal for ImmunoTherapy of Cancer这个杂志审稿快嘛

        3 回答 930 围观
        2023-04-01

        问

        American journal of cancer research投稿

        3 回答 800 围观
        2022-08-27

        问

        BMC cancer投稿求助

        2 回答 352 围观
        2022-08-20

        推荐阅读

        Subcloning of Ovarian Cancer Cell Lines

        The Use of Matrigel in the Establishment of Ovarian Carcinoma Cell Lines as Xenografts

        Isolation and Culture of Ovarian Cancer Cell Lines

        无忧采购 轻松科研

        无忧采购 轻松科研

        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序